GC
BSTC

Globeflex Capital’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Globeflex Capital’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,402
Closed -$127K – 533
2020
Q3 		$127K Sell
2,402
-298
-11% -$18.4K 0.03% 386
2020
Q2 		$165K Buy
+2,700
New +$156K 0.04% 411
2019
Q2 		– Sell
-6,802
Closed -$424K – 541
2019
Q1 		$424K Buy
6,802
+1,002
+17% +$66.3K 0.09% 314
2018
Q4 		$351K Hold
5,800
– – 0.08% 322
2018
Q3 		$339K Buy
5,800
+700
+14% +$35.7K 0.07% 356
2018
Q2 		$229K Buy
5,100
+800
+19% +$34.4K 0.05% 377
2018
Q1 		$191K Sell
4,300
-24
-0.6% -$1.01K 0.04% 386
2017
Q4 		$187K Hold
4,324
– – 0.05% 310
2017
Q3 		$201K Hold
4,324
– – 0.06% 294
2017
Q2 		$214K Sell
4,324
-34,731
-89% -$1.82M 0.05% 312
2017
Q1 		$2.14M Buy
39,055
+4,400
+13% +$233K 0.51% 32
2016
Q4 		$1.93M Sell
34,655
-500
-1% -$24K 0.48% 29
2016
Q3 		$1.61M Buy
+35,155
New +$1.41M 0.4% 60

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Globeflex Capital's BSTC Position: Q4 2020 in Review

Globeflex Capital sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 2,402 shares — an estimated $127K sold.

Globeflex Capital first reported a position in BSTC in Q3 2016 and held it in 13 quarters. The position peaked at $2.14M in Q1 2017. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Globeflex Capital reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Globeflex Capital sold 2,402 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $127K.
  • Globeflex Capital first reported a position in BioSpecifics Technologies Corp. in Q3 2016 and held it in 13 quarters.
  • Globeflex Capital's BioSpecifics Technologies Corp. position peaked at $2.14M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Globeflex Capital's 13F filing for Q4 2020, filed 11 Feb 2021.